Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HPV18 REGULATORY REGION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 22 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Stubenrauch, F; Zobel, T; Iftner, T
      The E8 domain confers a novel long-distance transcriptional repression activity on the E8-over-cap-E2C protein of high-risk human papillomavirus type31

      JOURNAL OF VIROLOGY
    2. Goodwin, EC; DiMaio, D
      Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    3. Nishimura, A; Ono, T; Ishimoto, A; Dowhanick, JJ; Frizzell, MA; Howley, PM; Sakai, H
      Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition

      JOURNAL OF VIROLOGY
    4. Francis, DA; Schmid, SI; Howley, PM
      Repression of the integrated papillomavirus E6/E7 promoter is required forgrowth suppression of cervical cancer cells

      JOURNAL OF VIROLOGY
    5. Naeger, LK; Goodwin, EC; Hwang, ES; DeFilippis, RA; Zhang, H; DiMaio, D
      Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repressionof cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein

      CELL GROWTH & DIFFERENTIATION
    6. GOODWIN EC; NAEGER LK; BREIDING DE; ANDROPHY EJ; DIMAIO D
      TRANSACTIVATION-COMPETENT BOVINE PAPILLOMAVIRUS E2 PROTEIN IS SPECIFICALLY REQUIRED FOR EFFICIENT REPRESSION OF HUMAN-PAPILLOMAVIRUS ONCOGENE EXPRESSION AND FOR ACUTE GROWTH-INHIBITION OF CERVICAL-CARCINOMA CELL-LINES

      Journal of virology
    7. STUBENRAUCH F; LIM HB; LAIMINS LA
      DIFFERENTIAL REQUIREMENTS FOR CONSERVED E2 BINDING-SITES IN THE LIFE-CYCLE OF ONCOGENIC HUMAN-PAPILLOMAVIRUS TYPE-31

      Journal of virology
    8. STUBENRAUCH F; COLBERT AME; LAIMINS LA
      TRANSACTIVATION BY THE E2 PROTEIN OF ONCOGENIC HUMAN-PAPILLOMAVIRUS TYPE-31 IS NOT ESSENTIAL FOR EARLY AND LATE VIRAL FUNCTIONS

      Journal of virology
    9. CAMPO MS
      BOVINE PAPILLOMAVIRUS AND CANCER

      Veterinary journal
    10. DESAINTES C; DEMERET C; GOYAT S; YANIV M; THIERRY F
      EXPRESSION OF THE PAPILLOMAVIRUS E2 PROTEIN IN HELA-CELLS LEADS TO APOPTOSIS

      EMBO journal
    11. FRATTINI MG; HURST SD; LIM HB; SWAMINATHAN S; LAIMINS LA
      ABROGATION OF A MITOTIC CHECKPOINT BY E2 PROTEINS FROM ONCOGENIC HUMAN PAPILLOMAVIRUSES CORRELATES WITH INCREASED TURNOVER OF THE P53 TUMOR-SUPPRESSOR PROTEIN

      EMBO journal
    12. YASUGI T; BENSON JD; SAKAI H; VIDAL M; HOWLEY PM
      MAPPING AND CHARACTERIZATION OF THE INTERACTION DOMAINS OF HUMAN PAPILLOMAVIRUS TYPE-16 E1 AND E2 PROTEINS

      Journal of virology
    13. GARRIDOGUERRERO E; CARRILLO E; GUIDO M; ZAMORANO R; GARCIACARRANCA A; GARIGLIO P
      DIFFERENT ARRANGEMENT OF HUMAN PAPILLOMAVIRUS E2 BINDING-SITES DISTINGUISHES CUTANEOUS TYPES FROM THOSE ASSOCIATED WITH MUCOSAL LESIONS

      Archives of medical research
    14. KOVELMAN R; BILTER GK; GLEZER E; TSOU AY; BARBOSA MS
      ENHANCED TRANSCRIPTIONAL ACTIVATION BY E2 PROTEINS FROM THE ONCOGENICHUMAN PAPILLOMAVIRUSES

      Journal of virology
    15. DOWHANICK JJ; MCBRIDE AA; HOWLEY PM
      SUPPRESSION OF CELLULAR PROLIFERATION BY THE PAPILLOMAVIRUS E2 PROTEIN

      Journal of virology
    16. WIKSTROM A
      CLINICAL AND SEROLOGICAL MANIFESTATIONS OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION

      Acta dermato-venereologica
    17. BOUVARD V; STOREY A; PIM D; BANKS L
      CHARACTERIZATION OF THE HUMAN PAPILLOMAVIRUS E2 PROTEIN - EVIDENCE OFTRANSACTIVATION AND TRANSREPRESSION IN CERVICAL KERATINOCYTES

      EMBO journal
    18. LEMOAL MA; YANIV M; THIERRY F
      THE BOVINE PAPILLOMAVIRUS TYPE-1 (BPV1) REPLICATION PROTEIN E1 MODULATES TRANSCRIPTIONAL ACTIVATION BY INTERACTING WITH BPV1 E2

      Journal of virology
    19. USHIKAI M; LACE MJ; YAMAKAWA Y; KONO M; ANSON J; ISHIJI T; PARKKINEN S; WICKER N; VALENTINE ME; DAVIDSON I; TUREK LP; HAUGEN TH
      TRANS ACTIVATION BY THE FULL-LENGTH E2 PROTEINS OF HUMAN PAPILLOMAVIRUS TYPE-16 AND BOVINE PAPILLOMAVIRUS TYPE-1 IN-VITRO AND IN-VIVO - COOPERATION WITH ACTIVATION DOMAINS OF CELLULAR TRANSCRIPTION FACTORS

      Journal of virology
    20. KARLEN S; BEARD P
      IDENTIFICATION AND CHARACTERIZATION OF NOVEL PROMOTERS IN THE GENOME OF HUMAN PAPILLOMAVIRUS TYPE-18

      Journal of virology
    21. MUNGER K; PHELPS WC
      THE HUMAN PAPILLOMAVIRUS-E7 PROTEIN AS A TRANSFORMING AND TRANSACTIVATING FACTOR

      Biochimica et biophysica acta
    22. ROMANCZUK H; HOWLEY PM
      DISRUPTION OF EITHER THE E1-REGULATORY OR THE E2-REGULATORY GENE OF HUMAN PAPILLOMAVIRUS TYPE-16 INCREASES VIRAL IMMORTALIZATION CAPACITY

      Proceedings of the National Academy of Sciences of the United Statesof America


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 06:54:17